Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Cash from Financing Activities (2020 - 2026)

Petco Health & Wellness Company's Cash from Financing Activities history spans 7 years, with the latest figure at -$96.4 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 10025.63% year-over-year to -$96.4 million; the TTM value through Jan 2026 reached -$101.7 million, down 1062.29%, while the annual FY2026 figure was -$101.7 million, 1062.29% down from the prior year.
  • Cash from Financing Activities reached -$96.4 million in Q1 2026 per WOOF's latest filing, down from -$1.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of -$266000.0 in Q3 2024 to a low of -$96.4 million in Q1 2026.
  • Average Cash from Financing Activities over 5 years is -$13.7 million, with a median of -$4.7 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: surged 99.07% in 2024, then crashed 10025.63% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at -$4.7 million in 2022, then crashed by 288.85% to -$18.3 million in 2023, then skyrocketed by 89.56% to -$1.9 million in 2024, then surged by 43.87% to -$1.1 million in 2025, then crashed by 8900.56% to -$96.4 million in 2026.
  • Per Business Quant, the three most recent readings for WOOF's Cash from Financing Activities are -$96.4 million (Q1 2026), -$1.1 million (Q4 2025), and -$3.9 million (Q3 2025).